Evaluation of the Efficacy and Tolerability of the LED Mask With or Without the Serum Formula on the Signs of Facial Photodamage .
Evaluation of the Efficacy and Tolerability of the LED Mask With or Without the Serum Formula on the Signs of Facial Photodamage
Main objective : To evaluate the anti-aging effectiveness of the LED mask alone on at least one studied anti-aging parameters (including some targeted wrinkles) after 3 months versus baseline
Secondary objectives:
- Anti-aging clinical score (radiance, skin tone, fine line, ptose, plumpness, ..)
- Evaluate the consumer perception (self-evaluation)
- Tolerance
- Standardized pictures (all light) and pictures analysis
- Comparison of effectiveness between the 2 groups (with and without formula
研究概览
详细说明
Rational Photodamaged/aged facial skin is characterized by thinner and drier skin, with increasing sags and wrinkles due to the loss of collagen and elastic tissue. Aging skin is also much more susceptible to the development of brown spots and pigmentation.
The use of LED masks to combat skin aging is based on a scientific principle called photobiomodulation. Red and near-infrared light stimulates cellular repair mechanisms without heating or damaging tissues. Its safety profile is well-documented across all skin types and side effects of phototherapy have been shown as being minimal and temporary.
Design:
Prospective, monocentric, open, non-randomized study conducted in healthy female participant aged 35 to 60 years.
The clinical investigation is design to evaluate the efficacy and tolerability of a LED mask with or without a serum formula on the anti-aging signs of the face.
There are 2 different groups:
Group 1: investigational device alone /Group 2: investigational device + cosmetic serum. Inclusion in each group will not be randomized but will be sequential: group 1 first and then group 2.
the evaluation times are : baseline, Timmedialy, after 7 days (D7), after one month (T1M), after 2 months (T2M), after 3 months (3M) Reglementation The clinical investigation will be conducted in compliance with Good Clinical Practice (GCP) guidelines and applicable regulatory requierement for medical device investigation, ISO 14155 Statistic Safety analyses will be performed on the SS population, while efficacy analyses will be primary performed on the ITT population. If the sample size between the PP and ITT differs by more than 10%, the efficacy analysis will also be performed on the PP population.
Evaluations criterias Clinical Grading of Efficacy Parameters Assessed with scale 10 grade -point scale (0-9) or atlas photonumeric for the items : Fine lines, Roughness , Skin tone evenness, Radiance , Plumpness, Firmness, Suppleness, Elasticity, Forehead wrinkles, Glabella wrinkles, Crow's feet wrinkles, Wrinkles on the corner of lips, Ptosis on the lower face , Nasolabial fold.
The significant change versus baseline for each item will be evaluated at each time point.
The self assessment efficacy questionnaire:
The answers to the efficacy questionnaire will be summarized in the frequency table by category , together with 100% stacked bar charts.
Safety Assessment AEs will be listed by participant including time of onset, time from the first administration of clinical investigation drug, duration, intensity, action taken, corrective therapies, outcomes, relationship to clinical investigation drug and serousness.
Th dermatologist will assess the overall tolerance on a 4-grade (Very good (1); Good (2); Moderate (3); Bad (4)) at each visits.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Audrey Natalizio, Clinical Project Manager
- 电话号码:+ 33(0) 472 82 36 56
- 邮箱:Audrey.Natalizio@cpt.eurofinseu.com
学习地点
-
-
New Jersey
-
Piscataway、New Jersey、美国、08854
- Eurofins CRL
-
-
参与标准
资格标准
适合学习的年龄
- 成人
接受健康志愿者
描述
Inclusion Criteria:
- Female subjects aged between 35-60y.o
- Presenting all skin types
- Presenting all phototype according to Fitzpatrick Classification
- Sensitive skin (50%) - declarative
- Daily user of SPF30 or 50+ for at least 30 days
- User or not of LED masks (collected data)
- Mask adapted to the shape of the face
- Having mild to moderate scores (as indicated) for the items parameters
- Subjects willing not to change their face/eyes make-up removal products and habits, and shower habits (e.g. shampoo, shower gel), and make-up products (eyes and mouth) throughout the course of the study.
- Subjects willing to use the investigational devices and/or products on the face throughout the course of the study period
- Subjects taking an effective oral contraception or other methods of contraception for the duration of the study
- Written Informed Consent Form to participate in the study
- illingness and ability to comply with protocol requirements
Exclusion Criteria:
- Subjects having allergy or sensitivity to LED Light
- Subjects having at risk of epilepsy
- subject who may have headaches
- Subjects having participated in the clinical study using anti-aging formula on the face within at least 3 months preceding the baseline visit
- Subjects having used any cosmetic products with exfoliating or astringing allegation on the face within at least 4 weeks preceding the baseline visit
- Subject with arterial circulatory disorders in the treated area,
- Subjects with sensitivity troubles and pain perception impairment, facial paralysis,
- Subjects with degenerative and vascular retinal disease,
- Subjects with known problems of scarring or wound healing,
- History of photosensitivity or photo allergy
- History of chronic viral infections (herpes simplex, ZONA…) and last outbreak within 12 months preceding the baseline visit
- Subject having an underlying dermatological disease or conditions on the face, which in the investigator's opinion, could interfere with study evaluation
- Subjects with a melanoma history in the family (parents or grandparents)
- Subjects undergone the radiotherapy in the treated areas,
- Subject having excessive moles, excessive pigmented spots, tattoos, scars, irritated skin, etc. at the test area that could influence the investigation
- Subject with a history of surgery to the treatment concerned areas within 6 months preceding the baseline visit
- Subject reports (or plans to) sunbath or overexpose to UV-light (mountains sports, phototherapy, tanning salon use…) for aesthetic or therapeutic reason one month before the study start (or during the study).
- Subject having modified their cosmetic habits (moisturizing skin care, cleansers, make-up removers, make-up, shower products, shampoo…) during the 2 weeks before baseline visit.
Subject uses or has used any of the medications or topical treatments/skincare products/procedure below without relevant wash-out period before the baseline visit (or is unwilling or unable to accept to follow the wash-out period below during the study)
-
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:非随机化
- 介入模型:顺序分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:ARM 1 : MASK LED ALONE
Participant aged between 40 and 55 years who presents signs of photodamage on the face as well as anti-aging signs (wrinkles, complexion, luminosity)
|
Application of mask LED on the face, 5 times a week for 10 minutes for 3 months.
The participant will apply his usual moisturizer and sunscreen
|
|
有源比较器:ARM2 : DEVICE + COSMETIC FORMULA
Participant aged between 40 and 55 years who presents signs of photodamage on the face as well as anti-aging signs (wrinkles, complexion, luminosity)
|
application of the LED mask 5 times a week during 10 minutes and the cosmetic formula twice a day for 3 months Paticipant will apply his usual moisturizer and sunscreen
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Improvement of anti-aging parameters
大体时间:baseline to 3 months
|
The expert clinical grading will perform a standartied clinical evaluation oth the 14 anti-aging items with the scale 10 grade -point scale (0-9) or L'Oréal Skin Aging Atlas (scale photonumeric)
|
baseline to 3 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Global tolerance
大体时间:Immediate time to 3 months
|
The investigator will assign an overall tolerance score at each visit using the following scale 1: very good ; 2: good ; 3: Moderate ; 4 : Bad
|
Immediate time to 3 months
|
|
Self assessment questionnaire
大体时间:immediat time to 3 months
|
Participant will complete a subjective evaluation questionnaire to capture their perception of treatment outcomes.
The questionnaire, using a 5 point scale (1= Disagree to 5= Agree), will include items on visible results (confort, ease of use, improvement in overall skin appereance, satisfaction)
|
immediat time to 3 months
|
合作者和调查者
赞助
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- EV 2512-1248 MASK LED
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.